mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.098 |
0.07 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.097 |
0.07 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.07 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.07 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.07 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.07 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.07 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.08 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.08 |